Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
adverse drug reaction
anti MAG antibodies
antibodies to myelin basic protein
antimyelin antibodies
asymptomatic
axonal degeneration
axonal transection
Barkhof MR criteria for MS
BCG vaccination
BENEFIT study
brain atrophy
brain volume
brainstem
brainstem, lesion of
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, protein of
children
controversies in neurology
cop 1
corpus callosum, lesion of
demyelinating disease
diabetes insipidus
diagnostic criteria
disability rating scale, neurological
disability, neurological
efficacy
Epstein-Barr virus
evoked potentials
fourth ventricle, shift of
gadolinium
gammaglobulin therapy, intravenous
hearing loss
hearing loss, sudden, unilateral
heralding manifestation
herpes virus
hydrocephalus
hydrocephalus, exvacuo
immunomodulation
immunosuppressive agents
interferon
interferon beta 1-a
interferon beta 1-b
intravenous
McDonald criteria for MS
misdiagnosis
mitoxantrone
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, demyelinating disease
MRI, false negative
MRI, field strength
MRI, field strength, high
MRI, incidental finding
MRI, lesion burden
MRI, negative
MRI, optic nerve
MRI, serial
MRI, spinal cord
MRI, volumetry
MRS
multiple sclerosis
multiple sclerosis, asymptomatic
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, conversion to clinically definite
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, monosymptomatic
multiple sclerosis, MRI conversion
multiple sclerosis, MRI criteria
multiple sclerosis, pathogenesis
multiple sclerosis, preclinical
multiple sclerosis, prognosis
multiple sclerosis, prophylaxsis
multiple sclerosis, radiologically isolated syndrome
multiple sclerosis, relapsing
multiple sclerosis, risk factors for
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
N-acetyl-L-aspartic acid
neurologic disease, diagnoses of
neurologic signs
neurologic symptoms
neuropathology
neuroprotective agents
optic nerve, lesion of
optic neuritis
optic neuritis, etiology of
optic neuritis, treatment of
optical coherence tomography
periventricular leukomalacia
posterior fossa
posterior fossa, lesion of
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
protein 14-3-3, cerebrospinal fluid
review article
risk factors
safety
sensorineural hearing loss
serologic testing
spinal cord
spinal cord, lesion of
steroid
steroid therapy, CNS treatment and complications with
symmetric brain lesions
symptomatic
tinnitus
treatment of neurologic disorder
ventricular enlargement
viral infection
visual evoked response
white matter disease, periventricular
Showing articles 1100 to 1150 of 4024 << Previous Next >>

Orbital and Optic Pathway Sarcoidosis:MR Findings
AJNR 15:775-783, Carmody,R.F.,et al, 1994

Leber's Hereditary Optic Neuropathy Mitochondrial DNA Mutations in Multiple Sclerosis
Ann Neurol 36:109-112, Kellar-Wood,H.,et al, 1994

Uhthoff's Symptom in Disorders of the Anterior Visual Pathways
Neurol 44:1036-1038, Lepore,F.E., 1994

Antiphospholipid Antibody Syndrome Mimicking Multiple Sclerosis Clinically and by Magnetic Resonance Imaging
Arch Int Med 154:917-920, Scott,T.F.,et al, 1994

Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994

Chronic Systemic High-Dose Recombinant Interferon Alfa-2a Reduces Exacerbation Rate & MRI Signs in MS
Neurol 44:406-413, Durelli,L.,et al, 1994

Treatment of Multiple Sclerosis
Lancet 343:275-279, Ebers,G.C., 1994

4-Aminopyridine in the Treatment of Patients with Multiple Sclerosis:Long-term Efficacy and Safety
Arch Neurol 51:292-296, Polman,C.H.,et al, 1994

A Genetic Marker and Family History Study of the Upstate New York Multiple Sclerosis Cluster
Neurol 44:329-333, Schiffer,R.B.,et al, 1994

The Value of Diagnostic Information to Patients with Suspected Multiple Sclerosis
Arch Neurol 51:67-72, Mushlin,A.I.,et al, 1994

Effect of Diagnostic Testing for Multiple Sclerosis on Patient Health Perceptions
Arch Neurol 51:46-51, O'Connor,P.,et al, 1994

Pathogenesis of Multiple Sclerosis
Lancet 343:271-275, Ffrench-Constant,C., 1994

The British Isles Survey of Multiple Sclerosis in Twins
Neurol 44:11-15, Mumford,C.J.,et al, 1994

Treatment of Paroxysmal Symptoms in Multiple Sclerosis with Ibuprofen
Neurol 44:571-572, Khan,O.A., 1994

Magnetic Resonance Evaluation of Disease Activity During Pregnancy in Multiple Sclerosis
Neurol 44:327-329, vanWalderveen,M.A.A.,et al, 1994

Concentric Sclerosis (Balo) :Morphometric and In Situ Hybridization Study of Lesions in Six Patients
Ann Neurol 35:18-30, Yao,D-L.,et al, 1994

Movement Disorders Following Lesions of the Thalamus or Subthalamic Region
Mov Disord 9:493-507, Lee,M.S. &Marsden, C.D., 1994

Methylprednisolone in Multiple Sclerosis:A Comparison of Oral with Intravenous Therapy at Equivalent High Dose
JNNP 56:1219-1220, Alam,S.M.,et al, 1993

Spinal Cord MRI Using Multi-Array Coils and Fast Spin Echo, II. Findings in Multiple Sclerosis
Neurol 43:2632-2637, Kidd,D.,et al, 1993

Trauma and Multiple Sclerosis:A Population-Based Cohort Study from Olmsted County, Minnesota
Neurol 43:1878-1882, 18711993., Siva,A.,et al, 1993

Seizures Due to Multiple Sclerosis:Seven Patients with MRI Correlations
JNNP 56:1317-1320, Thompson,A.J.,et al, 1993

Sudden Hearing Loss as the Initial Monosymptom of Multiple Sclerosis
Neurol 43:2703-2705, Drulovic,B.,et al, 1993

The Accuracy of Magnetic Resonance Imaging in Patients with Suspected Multiple Sclerosis
JAMA 269:3146-3151, Mushlin,A.I.,et al, 1993

Assessment of MRI Criteria for a Diagnosis of MS
Neurol 43:905-909, Offenbacher,H.,et al, 1993

Clinical Worsening in MS is Associated with Incr'd Freq & Area of Gadopenetate Dimeglumine-enhancing MRI Lesions
Ann Neurol 33:480-489, Smith,M.E.,et al, 1993

Transverse Myelitis, Retrosp Analy of 33 Cases, with Diff Cases Assoc with MS & Parinfectious Events
Arch Neurol 50:532-535, Jeffery,D.R.,et al, 1993

Facial Asymmetry, Hippocampal Pathology, & Remote Symptomatic Seizures:A Temporal Lobe Epileptic Syndrome
Neurol 43:725-727, Cascino,G.D.,et al, 1993

Update on Surgical Treatment of the Epilepsies, Second Intern Palm Desert Conf on Surgical Trtm of Epilepsies (1992)
Neurol 43:1612-1617, Engel,J.Jr., 1993

Functional Abilities at Age 4 Years of Children Born Before 29 Weeks of Gestation
BMJ 306:1715-1718, Johnson,A.,et al, 1993

Magnetic Resonance Imaging in Childhood Intractable Partial Epilepsies:Pathologic Correlations
Neurol 43:681-687, Kuzniecky,R.,et al, 1993

Detection of Hippocampal Pathology in Intractable Partial Epilepsy
Neurol 43:1793-1799, Jackson,G.D.,et al, 1993

Measurement of Whole Temporal Lobe and Hippocampus for MR Volumetry:Normative Data
Neurol 43:2006-2010, Bhatia,S.,et al, 1993

Genetic Susceptibility in Familial Multiple Sclerosis not Linked to the Myelin Basic Protein Gene
Lancet 341:1179-1181, Rose,J.,et al, 1993

Psychological Stress as Risk Factor for Exacerbations in Multiple Sclerosis
Neurol 43:1311-1312, Nisipeanu,P.&Korczyn,A.D., 1993

Anatomic-Radiologic Basis of Lhermitte's Sign in Multiple Sclerosis
Arch Neurol 50:849-851, Gutrecht,J.A.,et al, 1993

Devic's Neuromyelitis Optica:A Clinicopathological Study of 8 Patients
Ann Neurol 34:162-168, Mandler,R.N.,et al, 1993

Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993

Interferon Beta-1b is Effective in Relapsing Remitting MS, MRI Analysis Results of Placebo-Control Trial
Neurol 43:662-667, 6411993., Paty,D.W.,et al, 1993

Plasmapheresis in Acute Episodes of Fulminant CNS Inflammatory Demyelination
Neurol 43:1100-1104, Rodriquez,M.,et al, 1993

Long-Term Safety of Azathioprine Therapy in Multiple Sclerosis
Neurol 43:831-833, Amato,M.P.,et al, 1993

Intermittent Cyclophosphamide Pulse Therapy in Progressive MS:NE Coop MS Trtm Grp
Neurol 43:910-918, Weiner,H.L.,et al, 1993

Collosal Disconnection in Multiple Sclerosis
Neurol 43:1243-1245, Schnider,A.,et al, 1993

Systemic Histiocytosis Presenting as Multiple Sclerosis
Ann Neurol 33:549-554, Smith,M.E.,et al, 1993

Spinal Fluid Cells and Protein in Amyotrophic Lateral Sclerosis
Arch Neurol 50:489-491, Norris,F.H.,et al, 1993

Brain Magnetic Resonance Imaging in Acute Optic Neuritis, Experience of the Optic Neuritis Study Group
Arch Neurol 50:841-846, Beck,R.W.,et al, 1993

Congruous Quadrantanopia and Optic Radiation Lesion
Neurol 43:1430-1432, Borruat,F.X.,et al, 1993

Recovery of Functional Status After Stroke, A Postrehabilitation Follow-up Study
Stroke 24:200-250, Ferrucci,L.,et al, 1993

Measuring Physical Impairment and Disability with the Chedoke-McMaster Stroke Assessment
Stroke 24:58-63, Gowland,C.,et al, 1993

A Population-Based Study of Multiple Sclerosis in Twins:Update
Ann Neurol 33:281-285, Sadovnick,A.D.,et al, 1993

Magnetic Resonance Imaging of Spinal Cord in MS by Fluid-Attenuated Inversion Recovery
Lancet 341:593-594, Thomas,d.J.,et al, 1993



Showing articles 1100 to 1150 of 4024 << Previous Next >>